Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing. | Front Oncol | 2022 | 36033501 | PubTator, text mining | PubMed |
| Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS. | J Clin Med | 2022 | 36013147 | PubTator, text mining | PubMed |
| MicroRNAs and the Diagnosis of Childhood Acute Lymphoblastic Leukemia: Systematic Review, Meta-Analysis and Re-Analysis with Novel Small RNA-Seq Tools. | Cancers (Basel) | 2022 | 36010971 | PubTator, text mining | PubMed |
| SALL4: An Intriguing Therapeutic Target in Cancer Treatment. | Cells | 2022 | 36010677 | PubTator, text mining | PubMed |
| Properties of Leukemic Stem Cells in Regulating Drug Resistance in Acute and Chronic Myeloid Leukemias. | Biomedicines | 2022 | 36009388 | PubTator, text mining | PubMed |
| HOXA Amplification Defines a Genetically Distinct Subset of Angiosarcomas. | Biomolecules | 2022 | 36009018 | PubTator, text mining | PubMed |
| Current status and future perspectives in targeted therapy of NPM1-mutated AML. | Leukemia | 2022 | 36008542 | PubTator, text mining | PubMed |
| Presence of the GFI1-36N single nucleotide polymorphism enhances the response of MLL-AF9 leukemic cells to CDK4/6 inhibition. | Front Oncol | 2022 | 36003783 | PubTator, text mining | PubMed |
| A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia. | Lipids Health Dis | 2022 | 36002858 | PubTator, text mining | PubMed |
| Pre-diagnostic DNA methylation in blood leucocytes in cutaneous melanoma; a nested case-control study within the Norwegian Women and Cancer cohort. | Sci Rep | 2022 | 35987900 | PubTator, text mining | PubMed |
| MiR-27a downregulates 14-3-3θ, RUNX1, AF4, and MLL-AF4, crucial drivers of blast transformation in t(4;11) leukemia cells. | Cell Biochem Funct | 2022 | 35981137 | PubTator, text mining | PubMed |
| Clinical significance of STING expression and methylation in lung adenocarcinoma based on bioinformatics analysis. | Sci Rep | 2022 | 35978045 | PubTator, text mining | PubMed |
| Modulating biomolecular condensates: a novel approach to drug discovery. | Nat Rev Drug Discov | 2022 | 35974095 | PubTator, text mining | PubMed |
| The molecular understanding of super-enhancer dysregulation in cancer. | Nagoya J Med Sci | 2022 | 35967935 | PubTator, text mining | PubMed |
| Phase-separation antagonists potently inhibit transcription and broadly increase nucleosome density. | J Biol Chem | 2022 | 35963432 | PubTator, text mining | PubMed |
| A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value. | Front Oncol | 2022 | 35957912 | PubTator, text mining | PubMed |
| Single-cell analysis of transcription factor regulatory networks reveals molecular basis for subtype-specific dysregulation in acute myeloid leukemia. | Blood Sci | 2022 | 35957668 | PubTator, text mining | PubMed |
| Epigenetic reader SP140 loss of function drives Crohn's disease due to uncontrolled macrophage topoisomerases. | Cell | 2022 | 35952671 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Role of circular RNAs in the diagnosis, regulation of drug resistance and prognosis of lung cancer. | Oncol Lett | 2022 | 35949591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=38